Half a decade ago, money began to flow into the cannabis industry on the heels of first-mover momentum and pie-in-the-sky possibilities for a relatively lightly populated market. As we make our way through 2020, we are facing what could be the largest drop in market valuations since the great depression. Investors have begun to more closely examine where their money is going, and how they can ensure returns that fall in line with expectations. With that comes increased parameters, which include, among other things, a fundamental shift from equity financing to debt, to ensure some downside protection for investors. Join us to take a look at how the changing landscape has changed the identity of money flowing into the industry.
This program is eligible for 1 hours of General CLE credit in 60-minute states, and 1.2 hours of General CLE credit in 50-minute states. Credit hours are estimated and are subject to each state’s approval and credit rounding rules.
INCBA webinars are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted. For many live events, credit approval is not received prior to the program.
INCBA on demand programs are eligible for credit in the following states: AR, AL, AK, AZ, CA, CO, CT,DE, GA, HI, IL, IN, MN, MS, MO, NV, NH, NJ, NM, NY, NC, ND, OH, OR, PA, TN, TX, UT, VT, WV, and WI . Additional states may be available for credit upon self-application by attendees. States typically decide whether a program qualifies for MCLE credit in their jurisdiction 4-8 weeks after the program application is submitted.
For current accreditation status, please select your jurisdiction below.
Samantha Gleit is a partner at Feuerstein Kulick, focusing on debt and equity financing, corporate restructuring, alternative capital sources, acquisition financing, and related corporate transactions. Throughout her career, Samantha has advised investors on distressed debt and collateralization in highly regulated industries. She is known for implementing tailored, regulatory-compliant, loan and workout structures designed to maximize protection in the evolving cannabis legal landscape. Samantha also has extensive experience advising companies (ranging from startups to large public companies) on risk management, debt structuring, workouts, acquisition strategy, capitalization, and compliance. Beyond traditional legal advice, Samantha assists startups and growing companies identify liquidity sources, develop expansion strategies and negotiate efficient financing solutions.
Tahira Rehmatullah is President of T3 Ventures, Partner at Highlands Venture Partners, and member of the board of directors for Akerna Corp., Ceres Acquisition Corp., and Superette. From brand building to hedge funds, Tahira has previously held positions at Hypur Ventures, MTech Acquisition Corp., Marley Natural, Privateer Holdings, City First Enterprises, Perry Capital, and Ernst & Young. She is an investor and advisor to numerous cannabis and hemp businesses and entrepreneurs. She also serves on the advisory board of The Initiative and the Last Prisoner Project, and is dedicated to developing female and minority leadership in the industry. Tahira earned her MBA from the Yale School of Management and B.S. in Finance from The Ohio State University. She resides in New York City.
Nick is the Co-Founder, CEO and Vice Chairman of Columbia Care, Inc. (“CC”). Based in NYC and founded in 2012 to cultivate, manufacture, develop and distribute cannabis products to institutions and consumers, CC is one of the world’s largest, fully-integrated medical cannabis companies, licensed to operate in 17 US states and the EU. With product being sold from California to Germany, CC has over 1500 employees globally and a full portfolio of hemp derived OTC CBD products, adult use cannabis products and the leading pharmaceutical grade medical marijuana products – recommended by many of the most respected medical centers in the US. With ongoing research initiatives across a number of therapeutic categories, CC collaborates with KOLs and scientists from world-renowned institutions such as Mount Sinai (data analytics), Columbia (opioid substitution study funded by NIH), Montefiore (opioid replacement and pain management), Harvard Medical School (pain management), The Center for Discovery (seizure disorders), Westmed (Rheumatoid conditions and Lupus) and King’s College London (Schizophrenia and Bi-Polar Disorders in collaboration with the Wellcome Trust).
Prior to founding Columbia Care, Nick was a Partner at Apelles Investment Management, LLC, a private investment management company focused on healthcare and privatized military infrastructure, a Partner and Healthcare Portfolio Manager at ARX Investment Management and worked in the Investment Banking Division at Goldman, Sachs & Co. Inc., as an Analyst, Associate and Vice President. Nick is a graduate of Columbia College, Columbia University where he was a member of the Men’s Varsity Heavyweight Crew Team and President of Saint Anthony Hall.
In 2018 Nick was awarded a Tribeca Film Festival Disruptive Innovation Award for his efforts to combat the US opioid crisis. He has served as a guest lecturer at leading universities and corporate and philanthropic advisory boards including GenNext, Success Academy, Deerfield Club of New York, NY State Industrial Hemp Working Group and US Attorney’s (Eastern District, NY) Counterterrorism Working Group (Disruption and Early Engagement). Nick currently resides in Greenwich, Connecticut with his family and is a Knight of the Sovereign Military Hospitaller Order of Saint John of Jerusalem, of Rhodes and of Malta.
Please wait ...